# PYQUVI
> **ANDA219417** · Abbreviated New Drug Application (Generic) · Sponsor: AUCTA · Approved 2025-06-30
## Drug
- **FDA Application Number:** ANDA219417
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PYQUVI
- **Generic name:** DEFLAZACORT
- **Active ingredients:** DEFLAZACORT
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUCTA
- **Manufacturer:** Aucta Pharmaceuticals, Inc.
- **First approval:** 2025-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219417)
---
*MORVS · CC0 1.0*